LecTec Corporation
LecTec Corporation licenses topical patches that deliver over-the-counter drugs through the skin. Its patents, used by pharmaceutical companies, include adhesive patches, wound dressings, and inhalation therapies. LecTec formerly made its products, but ceased manufacturing a few years ago and is now an intellectual property licensing and holding company. LecTec licenses its technology to Novartis for that company's Triaminic Vapor Patch, a cough suppressant for adults and children. LecTec is pursuing additional licensing agreements with Novartis, as well as seeking other licensing partners. It's also looking to expand its product portfolio through research and development opportunities.
Contact Details
Executives
Chairman
Judd A. Berlin
CEO, CFO, and Director
Greg Freitag